You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
同和藥業(300636.SZ)業績快報:2021年度淨利潤升14.72%至8036.6萬元
格隆匯 03-23 17:21

格隆匯3月23日丨同和藥業(300636.SZ)披露2021年度業績快報,報吿期內,公司合併財務報表實現營業總收入5.87億元,較上年同期增長34.91%;實現利潤總額8834.05萬元,較上年同期增長13.17%;實現歸屬於上市公司股東的淨利潤8036.60萬元,較上年同期增長14.72%;實現扣除非經常性損益後的歸屬於上市公司股東的淨利潤7838.59萬元,較上年同期增長16.53%。

公司 2021年經營業績增長的主要原因是:內銷收入較上年同期增長119.9%,營業收入佔比由2020年度的18.96%增長至2021年度的30.91%;加巴噴丁主要客户對新工藝的變更完成,銷量逐步提高;新產品如維格列汀、米拉貝隆、阿齊沙坦、替格瑞洛、達格列淨等品種銷售較上年同期均大幅增加。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account